David Veitch
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
David Veitch is Chief Executive Officer at Basilea Pharmaceutica AG since 2018, with employment at the firm starting in 2014.
Formerly, Mr. Veitch was President-European Operations at Savient Pharmaceuticals, Inc. from 2012 to 2013.
Prior to that, Mr. Veitch was SVP-European Marketing & Brand Commercialization at Bristol-Myers Squibb Pharmaceuticals Ltd. from 2007 to 2011.
Education includes an undergraduate degree from the University of Bristol.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BASILEA PHARMACEUTICA AG 0,19 % | 31/12/2025 | 25 660 ( 0,19 % ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Directeur Général | 19/04/2018 |
| Sociétés | Poste | Fin |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2013 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2011 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Savient Pharmaceuticals, Inc.
Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Basilea Pharmaceutica AG
Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national